Karah Parschauer - Feb 27, 2025 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Signature
/s/ Karah Parschauer
Stock symbol
RARE
Transactions as of
Feb 27, 2025
Transactions value $
-$128,224
Form type
4
Date filed
3/3/2025, 01:58 PM
Previous filing
Oct 21, 2024
Next filing
Mar 4, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$95.7K -2.23K -3.85% $42.93 55.8K Feb 27, 2025 Direct
transaction RARE Common Stock Sale -$32.5K -760 -1.36% $42.75 55K Feb 27, 2025 Direct
transaction RARE Common Stock Award $0 +14.5K +26.26% $0.00 69.7K Mar 1, 2025 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RARE Stock Option (Right to Buy) Award $0 +26.1K $0.00 26.1K Mar 1, 2025 Common Stock 26.1K $42.92 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F3 Includes 205 shares acquired on October 31, 2024 under the Company's Amended and Restated Employee Stock Purchase Plan
F4 On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.